Skip to main content
  Cornell University

MAE Publications and Papers

Sibley School of Mechanical and Aerospace Engineering

New article: Intermittent PTH Administration and Mechanical Loading Are Anabolic for Periprosthetic Cancellous Bone

Article:  Grosso, MJ; Courtland, HW; Yang, X; Sutherland, JP; Stoner, K; Nguyen, J; Fahlgren, A; Ross, FP; van der Meulen, MCH; Bostrom, MP; (2015)  “Intermittent PTH Administration and Mechanical Loading Are Anabolic for Periprosthetic Cancellous Bone”, Journal of Orthopaedic Research, 33(2):163-173

DOI

Abstract:  The purpose of this study was to determine the individual and combined effects on periprosthetic cancellous bone of intermittent parathyroid hormone administration (iPTH) and mechanical loading at the cellular, molecular, and tissue levels. Porous titanium implants were inserted bilaterally on the cancellous bone of adult rabbits beneath a loading device attached to the distal lateral femur. The left femur received a sham loading device. The right femur was loaded daily, and half of the rabbits received daily PTH. Periprosthetic bone was evaluated up to 28 days for gene expression, histology, and mu CT analysis. Loading and iPTH increased bone mass by a combination of two mechanisms: (1) Altering cell populations in a pro-osteoblastic/anti-adipocytic direction, and (2) controlling bone turnover by modulating the RANKL-OPG
ratio. At the tissue level, BV/TV increased with both loading (+53%, p<0.05) and iPTH (+54%, p<0.05). Combined treatment showed only small additional effects at the cellular and molecular levels that corresponded to a small additive effect on bone volume (+13% compared to iPTH alone, p>0.05). This study suggests that iPTH and loading are potential therapies for enhancing periprosthetic bone formation. The elucidation of the cellular and molecular response may help further enhance the combined therapy and related targeted treatment strategies.
(C) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Funding Acknowledgement:
National Institutes of Health [R01-AR056802]; Clinical Translational Science Center [UL1-RR024996]

Funding Text:
Grant sponsor: National Institutes of Health; Grant number: R01-AR056802; Grant sponsor: Clinical Translational Science Center; Grant number: UL1-RR024996.

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar